SN
Silvia Noiman
Founder of Imel Biotherapeutics
Israel
Overview
Silvia Noiman is a seasoned executive and serial entrepreneur based in Israel, known for founding and leading successful biotech companies such as Imel Biotherapeutics Inc and Eloxx Pharmaceuticals. With a strong background in bioinformatics, biopharmaceuticals, and drug development, she has also served on the boards of various biotech firms and invested in companies like Vico Therapeutics and ABAC Therapeutics at early stages.
Noiman's career highlights include founding cCAM Biotherapeutics, which was acquired by Merck in July 2015, and leading Eloxx Pharmaceuticals as Founder, Board Member, and CEO. Her expertise in entrepreneurship, clinical development, and biotechnology has made her a prominent figure in the Israeli biopharmaceutical industry.
Work Experience
Founder, CEO & Board Member
2019 - 2024
Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders.
Raised $15,049,713.00.
Board Member
2019 - 2024
Board Member
2018 - 2023
Venture partner, entrepreneur and executive
2010 - 2023
Board Member
2019 - 2022
Founder, Board Member & CEO
2013 - 2021
http://www.eloxxpharma.com/
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Raised $94,389,332.00 from Cystic Fibrosis Foundation, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation and Cystic Fibrosis Foundation.
Board Member
2018 - 2019
Co-Founder & Executive Chairwoman
2011 - 2015
Co-Founder & Executive Chairwoman
2010 - 2015
Founder, Executive Chairwoman, Director
2010 - 2015